Warkany syndrome

Warkany Syndrome 2, also known as Trisomy 8 Mosaicism Syndrome, is a rare chromosomal disorder characterized by the presence of an extra copy of chromosome 8 in some of the body's cells. This mosaicism results in a variety of clinical manifestations, including physical abnormalities, intellectual disability, and developmental delays. The syndrome was first described by Joseph Warkany, a prominent pediatrician and researcher, making significant contributions to the understanding of congenital malformations.

Etiology

Warkany Syndrome 2 is caused by a chromosomal anomaly where an individual has three copies (trisomy) of chromosome 8 in some, but not all, of their cells. This condition is referred to as mosaicism and arises from a mutation during cell division after fertilization. The extent and type of symptoms experienced by the individual can vary widely and are thought to be related to the proportion and distribution of trisomic cells throughout the body.

Symptoms and Signs

The clinical presentation of Warkany Syndrome 2 can vary significantly among affected individuals. Common physical features may include craniofacial abnormalities, such as a prominent forehead, deep-set eyes, a small jaw, and low-set ears. Other physical abnormalities might include skeletal anomalies like scoliosis and joint deformities, heart defects, and kidney problems. Intellectual disability and developmental delays are also common, though the severity can vary. Some individuals may have mild symptoms with minimal impact on daily functioning, while others may have significant disabilities.

Diagnosis

Diagnosis of Warkany Syndrome 2 typically involves a combination of clinical evaluation and genetic testing. Chromosomal analysis, such as karyotyping or fluorescence in situ hybridization (FISH), can identify the presence of trisomy 8 mosaicism. Prenatal diagnosis is also possible through amniocentesis or chorionic villus sampling (CVS), which can detect chromosomal abnormalities in the fetus.

Treatment

There is no cure for Warkany Syndrome 2, and treatment is symptomatic and supportive. Management may include surgical interventions to correct physical abnormalities, therapies to address developmental delays (such as physical, occupational, and speech therapy), and routine monitoring for potential complications associated with the syndrome. A multidisciplinary approach involving pediatricians, geneticists, surgeons, and therapists is often necessary to address the complex needs of individuals with this condition.

Prognosis

The prognosis for individuals with Warkany Syndrome 2 varies depending on the severity of symptoms and the presence of life-threatening complications. With appropriate medical and supportive care, many individuals can lead fulfilling lives. However, those with significant physical and intellectual disabilities may require lifelong assistance and care.

Epidemiology

Warkany Syndrome 2 is a rare condition, though the exact prevalence is unknown due to the variability in clinical presentation and the potential for mild cases to go undiagnosed. Both males and females are equally affected.

See Also

• Chromosome 8
• Mosaicism
• Trisomy
• Genetic Disorders

‎ ‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian